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Synaptic Innervation Density Is Regulated
by Neuron-Derived BDNF
Carrie G. Causing, Andrew Gloster, 1990; Patterson et al., 1992; Nawa et al., 1995), could
regulate synaptic innervation density from afferent in-Raquel Aloyz, Shernaz X. Bamji, Eddie Chang,
Jim Fawcett, George Kuchel*, and Freda D. Miller puts, thereby modulating long-term synaptic function.
Precedent for this hypothesis derives from the periph-Center for Neuronal Survival
Montreal Neurological Institute eral nervous system, where alterations in target organ-
derived NGF lead to terminal sprouting for both sympa-*Montreal General Hospital Research Institute
McGill University thetic and sensory neurons (Edwards et al., 1989; Miller
et al., 1994).Montreal H3A 2B4
Canada We have chosen to test this hypothesis at a well char-
acterized, accessible synapse: that of spinal pregangli-
onic neurons onto their sympatheticneuron targets. Pre-
vious work has provided insights into the potentialSummary
cellular mechanisms regulating innervation density at
this synapse (reviewed in Purves et al., 1988). WhenIn this report, we have examined the role of neuron-
sympathetic neurons are axotomized, their pregangli-derived BDNF at an accessible synapse, that of pre-
onic input is lost; this loss can be prevented by exoge-ganglionic neurons onto their sympathetic neuron tar-
nous NGF and mimicked by application of anti-NGFgets. Developing and mature sympathetic neurons
antibodies (Nja and Purves, 1977, 1978). Moreover, sym-synthesize BDNF, and preganglionic neurons express
pathetic neurons that project to small peripheral targetsthe full-length BDNF/TrkB receptor. When sympa-
receive sparse preganglionic input relative to those thatthetic neuron-derived BDNF is increased 2- to 4-fold in
innervate large target territories (Voyvodic, 1989); a simi-transgenic mice, preganglionic cell bodies and axons
lar increased preganglionic innervation can be achievedhypertrophy, and the synaptic innervation to sympa-
by application of exogenous NGF to intact animalsthetic neurons is increased. Conversely, when BDNF
(Schafer et al., 1983). Since preganglionic neurons them-synthesis is eliminated in BDNF 2/2 mice, pregangli-
selves do not respond to NGF (Schwab and Thoenen,onic synaptic innervation to sympathetic neurons is
1977; Oppenheim et al., 1982), these findings suggestdecreased. Together these results indicate that varia-
that target organ-derived NGF regulates synthesis of attions in neuronal neurotrophin synthesis directly regu-
least one sympatheticneuron-derived growth factor thatlate neuronal circuitry by selectively modulating syn-
in turn regulates preganglionic innervation density. Suchaptic innervation density.
a cascade of trophic factors could well play a key role
in modulating neuronal circuitry in response to alter-Introduction
ations in peripheral input (Purves and Lichtman, 1980).
What are the sympathetic neuron-derived factors thatThe neurotrophic factor hypothesis states that neuronal
modulate preganglionic innervation? One candidate forgrowth and survival are regulated by target-derived
this role is the neurotrophin brain-derived neurotrophicneurotrophic factors so that competition for limiting
factor (BDNF) (Barde et al., 1982; Leibrock et al., 1989),amounts of trophic factors match the number of in-
which is expressed by sympathetic neurons during em-nervating neurons to target cells (Oppenheim, 1991).
bryogenesis (Schecterson and Bothwell, 1992). BDNFHowever, the advent of targeted gene disruption has
does not lead to Trk receptor activation in sympatheticrevealed that, although this hypothesis is largely true
neurons, probably because these neurons only expressfor the PNS, the situation in the central nervous system
TrkA and TrkC (Belliveau et al., 1997), and sympathetic(CNS) is much more complex (reviewed in Snider, 1994).
neuron number is not reduced in number in BDNF 2/2A particularly striking example of this difference involves
mice (Ernfors et al., 1994). In this paper, we providenerve growth factor (NGF), the prototypic target-derived
evidence that BDNF is a sympathetic neuron-derivedneurotrophin (reviewed in Thoenen and Barde, 1980;
growth factor, and that variations in sympathetic neu-Levi-Montalcini, 1987). In NGF 2/2 mice, there is pro-
ron–derived BDNF selectively regulate synaptic densityfound loss of sympathetic and most sensory neurons
at this well characterized neuronal synapse.of the dorsal root ganglion, but no loss of the best char-
acterized NGF-responsive CNS population, the basal
Resultsforebrain cholinergic neurons (Crowley et al., 1994).
Recent studies have therefore focused on other roles
BDNF Protein Is Synthesized by Developingfor the neurotrophins in the CNS, including regulation
and Mature Sympathetic Neuronsof neuronal morphology and synaptic function. In partic-
BDNF mRNA has previously been detected by in situular, recent work indicates that at least one member
hybridization in mouse sympathetic ganglia from embry-of the neurotrophin family, BDNF, plays a key role in
onic day 14.5 (E14.5) to postnatal day 1 (P1) (Schecter-modulating both acute and long-term synaptic function
son and Bothwell, 1992). To confirm these findings, we(reviewed in Lo, 1995; Thoenen, 1995). However, the
precise molecular mechanisms underlying this modula- isolated RNA from postnatal day 1 superior cervical gan-
glia (SCG). Northern blot analysis of poly A1 RNA fromtion are still ill defined. In this regard, we have hypothe-
sized that alterations in neuronal BDNF synthesis, po- the SCG revealed two mRNA transcripts for BDNF simi-
lar in size to those from mouse L cells (Figure 1A).tentially as determined by neuronal activity (Zafra et al.,
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RNase-protection analyses confirmed that these tran-
scripts were indeed BDNF mRNA, and that a similar
size band was protected in RNA isolated from cultured
neonatal sympathetic neurons (data not shown), indicat-
ing that at least some of the BDNF mRNA in the SCG
was synthesized by neurons.
To determine whether BDNF was also made in the
adult SCG, and to confirm that the biologically active
protein was synthesized, we performed Western blot
analysis using an anti-BDNF antibody. To demonstrate
the specificity of this antibody, we performed three dif-
ferent controls. First, we confirmed that, of the recombi-
nant neurotrophins, this antibody recognized only BDNF
(Figure 1Bi), and that this antibody was able to recognize
as little as 0.5 ng of recombinant BDNF (data not shown).
Second, we demonstrated that a BDNF-immunoreactive
band of a size similar to both recombinant (data not
shown) and transfected BDNF was present in the brains
of BDNF 1/1 but not BDNF 2/2 mice (Figure 1Bii).
Third, we demonstrated that preabsorption of the anti-
body with the original BDNF peptide immunogen
blocked the ability of the antibody to detect brain-
derived BDNF on a Western blot (Figure 1Bii).
Having confirmed the specificity of this BDNF anti-
body, we next determined whether BDNF protein was
synthesized by sympathetic neurons of the SCG, as it
was in the mouse brain. Western blot analysis of protein
derived from the adult SCG revealed the presence of aFigure 1. Detection of BDNF mRNA and Protein in the Postnatal
BDNF-immunoreactive band similar in size to that seenSuperior Cervical Ganglion
in the brain, and to recombinant BDNF (Figure 1Di).(A) BDNF mRNA is expressed in the postnatal day 1 superior cervical
ganglion, as detected by Northern blot analysis. Poly A1 RNA from
L cells (LC) and the rat superior cervical ganglion (SCG), as well as BDNF Is Overexpressed 2- to 4-Fold in Sympathetic
poly A2 RNA from the rat brain (A2) were separated on formalde- Neurons of DBH:BDNF Mice
hyde-denaturing gels, transferred to nitrocellulose, and probed with These results indicated that BDNF protein of the same
a 32P-labeled riboprobe specific for BDNF mRNA. As previously
size as recombinant BDNF is synthesized by developingdescribed (Acheson et al., 1991), L cells expressed two BDNF tran-
and mature sympathetic neurons. To test thehypothesisscripts that were similar in size to those detected in the postnatal
that sympathetic BDNF functions as a target neuron-SCG. Sizes of the two transcripts are indicated on the right.
(B) Specificity of the anti-BDNF antibody. (i) To test the specificity derived factor for preganglionic neurons, we used the
of the anti-BDNF antibody, 50 ng each of human recombinant NGF, 1.6 kb promoter sequence from the 59 region of the
BDNF, NT-3, and NT-4, were Western blotted. The antibody strongly human dopamine-b-hydroxylase (DBH) gene to target
recognized the recombinant BDNF. (ii) To determine whether this
overexpression of BDNF to sympathetic neurons inantibody would recognize BDNF isolated from the mouse brain, 50
transgenic mice. This promoter has previously beenmg of protein was extracted from the brains of BDNF 2/2 (KO) and
demonstrated to specifically target expression to norad-BDNF 1/1 littermates (CON) at postnatal days 15–20. Western blot
analysis revealed that the antibody recognized a BDNF-immunore- renergic and adrenergiccell populations, including sym-
active band in the control, but not knockout brain. This band was pathetic neurons, with no ectopic expression (Hoyle et
the same size as recombinant BDNF (data not shown) and BDNF al., 1994). We therefore created a minigene comprised
in lysates (10 mg) from vaccinia virus–BDNF infected PC12 cells
(PC12). To further ensure the specificity of the BDNF antibody, the
antibody was preincubated (CON preab and KO preab) with an
excess of BDNF peptide immunogen. This peptide corresponds to spinal cords of individual D498 and control postnatal day 4 lit-
amino acids 128–147 of the carboxy terminus of the human BDNF termates were analyzed by Western blots. The levels of BDNF were
sequence. Note that preincubation eliminated the BDNF-specific similar in 3 control (CON SC) and 3 D498 (D498 SC) spinal cords at
band in the BDNF 1/1 brain. this age. 20 ng of recombinant human BDNF was used as a control
(C) Circulating BDNF is not detectable in the DBH:BDNF mice. (i) in this experiment.
To control for systemic BDNF in the circulation, sera from control (D) BDNF protein is expressed in the SCG of adult control and
(CON) and transgenic D498 (D498) animals were analyzed by West- DBH:BDNF mice, as detected by Western blot analysis. Cell or tissue
ern blot analysis. BDNF was not detectable in either case. (ii) To lysates were separated on polyacrylamide gels, transferred to nitro-
test the reliability of the BDNF extraction from blood, 50 ng of human cellulose, and probed with an antibody specific to BDNF. (i) A BDNF-
recombinant BDNF was added to the blood of a BDNF 2/2 mouse. immunoreactive band similar in size to BDNF produced by vaccinia
The serum was then extracted, and Western blot analysis was per- virus-infected PC12 cells (PC12) is detected in equal amounts of
formed (BDNF 1 Blood). Human recombinant BDNF was used as protein from the control adult mouse SCG (CON SCG) and in the
a control (BDNF). No degradation of exogenous BDNF was ob- SCG of line D498 DBH:BDNF transgenic mice (D498 SCG). (ii) A
served. (iii) BDNF levels are similar in the spinal cord of neonatal comparison of the amount of BDNF in equal amounts of protein
control and DBH:BDNF mice. To determine whether preganglionic isolated from the SCG of DBH:BDNF mice of lines D498 (D498 SCG)
neurons were exposed to increased BDNF in the spinal cord of and D481 (D481 SCG) indicate that line D498 expresses BDNF at
transgenic mice during the period of sympathetic innervation, the approximately two-fold higher levels.
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of the 1.6 kb DBH promoter fused to the BDNF open then one would predict that preganglionic neurons
reading frame, with an SV40 intron and polyadenylation would express the TrkB/BDNF receptor, and that, by
signal. A DNA fragment containing this minigene free of analogy to peripheral neurons, they would hypertrophy
vector sequences was isolated and used to generate in response to increased sympathetic BDNF. To test
transgenic founder animals. the first prediction,we performed immunocytochemistry
A total of four transgenic DBH:BDNF lines were exam- with an antibody specific to the full-length form of the
ined. Three of these four founder lines showed increased TrkB receptor (Allendoerfer et al., 1994) on spinal cord
expression of BDNF mRNA in the SCG, as detected by sections from thoracic levels 1–4, the region containing
Northern blot analysis (data not shown). BDNF mRNA preganglionic neurons that innervate the SCG.This anal-
levels were not increased in regions such as the cortex ysis demonstrated that preganglionic neurons located
or liver, which do not contain noradrenergic or adrener- in the interomediolateral (IML) region are immunoreac-
gic cell populations (data not shown). On the basis of tive for the full-length TrkB receptor (Figure 2F). As a
these results, two lines of animals, D498 and D481, both positive control, we observed specific cell body staining
of which expressed increased BDNF mRNA in the SCG, in motoneurons located in the ventral horn (data not
were chosen for more extensive analysis. shown). As a negative control, we performed immunocy-
To quantitate the level of overexpression of BDNF tochemistry using preimmune serum, and found no spe-
protein in sympathetic neurons from these two lines of cific staining in the IML or ventral horn (data not shown).
mice, we first performed Western blot analysis. This To test the second prediction, that preganglionic neu-
analysis demonstrated that BDNF protein was increased rons would hypertrophy in response to sympathetic neu-
approximately 4-fold and 2-fold, respectively, in the ron-derived BDNF, we measured the size of choline-
adult SCG of lines D498 and D481 relative to control acetyltransferase (ChAT)–positive cell bodies in the IML
mice of the same genetic background (Figure 1D). To between thoracic levels 1–4; ChAT is a specific marker
confirm that this overexpression took place in sympa- for preganglionic neurons. Image analysis on immuno-
thetic neurons, we performed immunocytochemistry for stained sections revealed that transgenic ChAT–positive
BDNF, using a BDNF antibody that is effective for immu- IML neurons had an increased cross-sectional area rela-
nocytochemistry, as previously demonstrated (Pat- tive to wild-type neurons (Figure 3A) (wild type: 69.86 6
terson et al., 1996). This analysis revealed that levels
1.89 mm2, D498: 78.87 6 1.87 mm2, mean 6 SE, p ,
of BDNF protein were increased in many but not all
0.001; n 5 3). When these cell sizes were organized into
sympathetic neurons in both lines of transgenic mice
bins and expressed as a percentage of the total ChAT-
relative to wild-type controls (data not shown); this pro-
positive IML cell population, there was a shift of the
moter has previously been reported to target transgene
entire population toward greater sizes (Figure 3B). Thus,
expression in anywhere from 5% to 95% of sympathetic
preganglionic, TrkB-positive neurons respond to in-neurons (Mercer et al., 1991).
creased sympathetic BDNF with somatic hypertrophy.To ensure that any observed effects on preganglionic
innervation were not due to systemic BDNF, we mea-
sured BDNF levels in the circulation. Western blot analy- Increased Sympathetic BDNF Leads
sis demonstrated that circulating BDNF was undetect-
to Preganglionic Hyperinnervation
able in either control or line D498 animals (Figure Ci).
of the SCGThis lack of detectable BDNF in the blood was not due
If sympathetic BDNF is a growth factor for preganglionicto its degradation, because when recombinant BDNF
neurons, then we would predict that increased BDNFwas added to the blood of BDNF 2/2 animals prior to
would lead to increased preganglionic innervation. Toanalysis, it was recovered intact (Figure 1Cii).
test this prediction, we first visualized presynaptic con-A second potential source of increased BDNF for pre-
tacts in the SCG by performing immunocytochemistryganglionic neurons in DBH:BDNF mice was the CNS.
with an antibody to synapsin, a presynaptic marker pro-Western blot analysis of various regions of the adult
tein. In wild-type ganglia, there was diffuse punctateCNS revealed that BDNF levels were only increased
staining (Figure 2A). In contrast, similar analysis of D498in the hindbrain (data not shown), as predicted if the
and D481 transgenic animals revealed an increase intransgene was expressed appropriately in noradrener-
both the density and pattern of synapsin immunostain-gic neurons (Hoyle et al., 1994). However, to directly
ing; synapsin-positive terminals in the transgenic ani-demonstrate that preganglionic neurons were not ex-
mals appeared as dense clusters on and around sympa-posed to increased BDNF at the time of preganglionic
thetic neurons within the ganglion (Figure 2B). To ensureinnervation of the SCG, we examined BDNF in the neo-
that these synaptic contacts originated from the pregan-natal spinal cord. Western blot analysis confirmed that
glionic neurons, we resected the cervical sympatheticlevels of BDNF were similar in the spinal cord of line
trunk (CST), which carries the incoming axons from theD498 versus control littermates at postnatal day 4 (Fig-
preganglionic neurons. Except for sparse punctateure 1Ciii). Thus, the only sources of increased BDNF for
staining due to intrinsic synaptic connections within thepreganglionic neurons in DBH:BDNF mice were their
ganglion, there was an almost complete disappearancesympathetic neuron targets.
of the dense, punctate synaptic staining when the CST
was resected, confirming that the majority of synapticPreganglionic Neurons Express Full-Length TrkB,
contacts in the transgenic SCG originated from the pre-and Hypertrophy in Response to Increased
ganglionic inputs (Figure 2C). To confirm that this in-Sympathetic Neuron-Derived BDNF
crease in synapsin staining reflected an increased num-If sympathetic neuron-derived BDNF functions as a tar-
get-derived growth factor for preganglionic neurons, ber of synapses within the SCG, we quantitated synapse
Neuron
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Figure 2. Immunocytochemical Analysis of DBH:BDNF Mice
Increased sympathetic expression of BDNFleads to an increased density of preganglionic synapses inthe SCG, as detected immunocytochemi-
cally using an antibody again a presynaptic terminal marker protein, synapsin.
(A–C) Synapsin was immunocytochemically localized in sections of SCG from adult control (A) and transgenic animals of line D498 (B). Note
that both the density and pattern of synapsin immunostaining differs, with large clusters of synapsin-immunoreactive terminals in the transgenic
ganglia (arrow). To demonstrate that the increased synapsin-positive terminals in the transgenic mice derived from preganglionic axons, the
CST was transected and, two weeks later, the SCG was immunostained for synapsin (C). This led to the disappearance of the vast majority
of synapsin-positive terminals, although a few presumably intrinsic synapses remained (arrow). In all three panels, sympathetic neuron cell
bodies are indicated by arrowheads.
(D and E) Sympathetic innervation of the pineal gland is similar in control and transgenic mice. To visualize sympathetic innervation, sections
of control (D) and line D481 (E) pineal glands were immunostained with an antibody specific to tyrosine hydroxylase. Note that the density
and pattern of tyrosine hydroxylase immunoreactivity was similar in both cases (arrows).
(F) Preganglionic neurons express full-length TrkB. Spinal cord sections at thoracic levels 1–4 were immunostained with an antibody specific
to the full-length form of TrkB, demonstrating that preganglionic neurons in the intermediolateral column (arrow) displayed TrkB immunoreactiv-
ity. Dotted lines demarcate the gray and white matter of the spinal cord. Scale bar 5 200 mm2.
density by electron microscopy (Figures 4G and 4H). (neurons per 0.033 mm2, wild type: 28.8 6 .91, D498:
21.3 6 .54, p , 0.0001; n 5 5 for wild type, n 5 4Sections from the SCG of adult control and line D498
mice were randomly sampled with a 41 mm2 grid, and for D498). When the synapse density was corrected for
these differences in neuronal density, the relative syn-the number of synapses within this defined area were
determined. This analysis demonstrated a 1.7-fold in- apse number/neuron in the DBH:BDNF mice was in-
creased approximately 2.5-fold (Figure 3E), confirm-crease in synapse density in the SCG of line D498 rela-
tive to control animals (wild type: 0.85 6 0.05, line D498: ing that increased sympathetic neuron–derived BDNF
caused an increase in preganglionic synaptic innerva-1.47 6 .18, p 5 0.014; n 5 3 animals each, at least 40
grids per animal). Plotting the number of synapses per tion density.
grid as a distribution histogram revealed that the in-
creased mean synapse density reflected a shift to larger Increased Sympathetic BDNF Leads to an Increase
in the Size but Not the Number of Preganglionicsynapse numbers in the entire population (Figure 5E).
To determine whether the increased synapse density Axons Innervating the SCG
In the peripheral nervous system, an increase in thein DBH:BDNF animals corresponded to an increase in
the number of synapses per neuron, we measured neu- amount of target organ–derived neurotrophin leads to
an increase in the density of innervation, as well as inronal density on cresyl violet-stained sections. Image
analysis demonstrated that the neuronal density was the number of neurons innervating that target, largely
as a consequence of increased neuronal survival (Alberssignificantly higher in control than in line D498 mice
BDNF and Neuronal Innervation
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et al., 1994). To determine whether the increased pre-
ganglionic innervation of the SCG in theDBH:BDNF mice
was accompanied by a similar increase in the number of
innervating preganglionic neurons, we examined cross-
sections of the preganglionic nerve, the CST, from adult
wild-type and transgenic D498 and D481 animals. Sur-
prisingly, electron microscopy (Figures 4A, 4B, 4D, and
4E) and axon profile counts showed no difference in the
number of axons within the transgenic versus wild-type
CST (wild type: 1259 6 57, D498: 1044 6 55, D481:
1011 6 95, p . 0.05; n 5 3). However, measurement of
axon sizes revealed a shift toward larger sizes of both
unmyelinated and myelinated axons in the transgenic
versus wild-type CST (Figures 4A, 4B, 4D, and 4E; Fig-
ures 5A–5D). This shift in size distribution was also re-
flected in an increase in the diameter of CST axons in
transgenic compared to wild-type mice (unmyelinated
axons, wild type: 0.75 6 .01 mm, D498: 0.85 6 0.02 mm,
D481: 0.96 6 0.02 mm, p , 0.0001; myelinated axons,
wild type: 1.41 6 0.04 mm, D498: 1.70 6 0.04 mm, D481:
1.76 6 0.05 mm, p , 0.001; n 5 3). Thus, hyperinnervation
of the SCG in DBH:BDNF mice was due to an increase
in the number of synaptic terminals per axon, and not
to an increase in the number of preganglionic axons,
and presumably neurons, innervating the SCG.
Sympathetic Neurons’ Size Is Increased
in DBH:BDNF Mice
A somewhat surprising phenotype observed in the
DBH:BDNF transgenic mice was a hypertrophy of sym-
pathetic neurons of the SCG (Figure 3C), which ac-
counted for the decreased neuronal density in line D498.
Image analysis quantitation revealed a significant in-
crease in the cross-sectional area of SCG neurons in
transgenic D498 and D481 mice relative to wild-type
controls (wildtype: 371.84 6 5.70 mm2, D498: 507.65 6
10.46 mm2, D481: 486.94 6 9.25 mm2, p , 0.001; n 5 3).
One potential explanation for this phenomenon is that
the TrkB receptor was aberrantly induced in response
to the increase in sympathetic BDNF, thereby leading to
autocrine/paracrine effects within the ganglia. However,
immunostaining revealed no TrkB-like immunoreactivity
in either transgenic or control SCG (data not shown).
Moreover, SCG cell counts revealed no significant in-
crease in the relative number of sympathetic neurons
in transgenic versus wild-type ganglia (p . 0.05). Finally,Figure 3. Quantitative Analysis of Neuronal Size and Synapse
tyrosine hydroxylase immunostaining of the pineal glandDensity
(Figures 2D and 2E) and the iris (data not shown), both(A and B) Preganglionic neurons hypertrophy in response to in-
of which receive sympathetic efferents exclusively fromcreased sympathetic neuron-derived BDNF. To determine the size
of preganglionic neurons in control versus transgenic mice, spinal
cord sections from thoracic levels 1–4 were stained for ChAT, and
the size of ChAT-positive neurons in the intermediolateral column
was determined by image analysis. (A) represents the average pre- (E) The relative density of synapses per sympathetic neuron is in-
ganglionic cell size, while (B) represents the size distribution of creased in response to increased neuron-derived BDNF in
ChAT-positive neurons in the IML of control versus transgenic ani- DBH:BDNF mice and decreased in response to an absence of BDNF
mals of line D498. Note that the small increase in average neuronal synthesis in BDNF 2/2 mice. To quantitate the relative synapse
size is due to a shift to greater size of the entire preganglionic number per neuron within the SCG, synapses were counted in elec-
population. tron microscopic sections of a defined area (41 mm2). The synapse
(C and D) Sympathetic neuron cell body size is increased in density was calculated and then corrected for neuronal density to
DBH:BDNF mice. (C) The average sympathetic neuron size is signifi- derive the relative synapse number/neuron (see the text). This analy-
cantly larger in transgenic animals of both lines D481 and D498 than sis demonstrated that relative synaptic innervation per neuron was
it is in control mice of the same genetic background. However, two significantly increased in line D498 transgenic mice (D498) relative
weeks following removal of the CST and the corresponding loss of to adult wild-type mice of the same genetic background (WT), and
preganglionic innervation, cell body sizes are similar in control and significantly decreased in two- to three-week-old BDNF 2/2 mice
transgenic mice of both lines (D). (2/2) relative to their control (1/1) littermates.
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Figure 4. EM Analysis of the CST and SCG of Transgenic Mice
(A, B, D, and E) Increased sympathetic neuron-derived BDNF leads to an increase in the size but not the number of preganglionic neurons
in the adult CST. Electron microscopy of cross-sections of the CST, which carries preganglionic axons to the SCG, demonstrates a hypertrophy
in the size of both unmyelinated and myelinated axons in adult control (A and B) versus DBH:BDNF mice of line D481 (D and E). Squares in
panels (A) and (D) indicate enlarged areas (B) and (E), respectively. Scale bars 5 13.4 mm (A and D) and 3.35 mm (B and E).
(C and F) A lack of BDNF synthesis in 2- to 3-week-old BDNF 2/2 mice leads to decreased preganglionic innervation to the SCG. Electron
microscopy of cross-sections of the 2- to 3-week-old CST in control (C) versus BDNF 2/2 (F) littermates revealed a decrease in both the
number and size of CST axons innervating the SCG. Scale bar 5 13.4 mm.
(G and H) Synapse determination in the SCG of control (G) and D498 (H) animals. To quantitate the number of active zone synapses found
within the SCG, only those synapses displaying pre- and postsynaptic membrane thickenings and synaptic vesicles were counted (arrows).
Gap/electrical junctions were not included (arrowhead in G). Scale bar 5 1.3 mm.
the SCG, revealed no apparent difference in the density DBH:BDNF mice was responsible for the hypertrophy.
To test this hypothesis, we resected the CST, therebyand pattern of sympathetic innervation; TH-positive ax-
ons appeared as a similar network of lattice-like nerve removing the preganglionic input, and analyzed sympa-
thetic neuron sizes two weeks later. These experimentsfibers and terminals in transgenic and control pineal
glands (Figures 2D and 2E). revealed that, when the preganglionic innervation was
removed, the difference in size of transgenic and wild-Since the transgenic sympathetic neurons were simi-
lar to control neurons with regards to all of these pa- type sympathetic neurons was eliminated (Figure 3D),
an effect due to both a decrease in size of the transgenicrameters, with the exception of cell body size, we hy-
pothesized that the increased preganglionic input in neurons and an increase in size in the wild-type neurons
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(wild type: 472.87 6 0.18 mm2, D498: 475.28 6 32.12
mm2, D481: 455.87 6 13.45 mm2, p . 0.05; n 5 3).
Preganglionic Innervation to the SCG
Is Decreased in BDNF 2/2 Mice
These data indicate that sympathetic neuron-derived
BDNF regulates the density of preganglionic innervation
at the preganglionic–sympathetic synapse. If this is true,
then one would predict that, in the BDNF 2/2 mice,
where sympathetic neuron number is not decreased
(Ernfors et al., 1994), preganglionic synaptic innervation
to the SCG would be decreased. To test this prediction,
we analyzed the SCG of 2- to 3-week-old BDNF 2/2
mice by electron microscopy. These studies demon-
strated that SCG synapse density per 41 mm2 grid was
decreased approximately 1.5-fold in BDNF 2/2 mice
relative to their wild-type littermates (wildtype 5 1.3 6
.17; BDNF 2/2 5 0.88 6 .06, p , 0.05; n 5 3 animals
each, at least 40 grids per animal). Plotting the number
of synapsesper grid asa distribution histogram revealed
that this decrease reflected a shift to smaller synapse
numbers for the entire population (Figure 5F).
To determine whether the decrease in synapse den-
sity in the BDNF 2/2 mice corresponded to a decrease
in the relative number of synapses per neuron, we mea-
sured neuronal density. Image analysis of 2- to 3-week-
old animals revealed that neuronal density was signifi-
cantly higher in BDNF 2/2 mice than in their BDNF 1/1
littermates (neurons per 0.033 mm2, BDNF 2/2: 47.7 6
.79, BDNF 1/1: 32.5 6 .76, p , 0.0001; n 5 3). When
the synapse density was corrected for these differences,
the relative synapse number/neuron in the BDNF 2/2
mice was approximately 2.2-fold lower than in BDNF
1/1 littermates (Figure 3E).
To determine whether the decreased synapse density
observed in theBDNF 2/2 mice was due to a decreased
number of synapses per axon, or to a decreased number
of preganglionic axons, we analyzed theCST by electron
microscopy. These studies demonstrated that both the
number and size of axons in the CST were decreased
in 2- to 3-week-old BDNF 2/2 mice (Figures 4C and
4F). In 2- to 3-week-old control littermates, the mean
number of axons in the CST was 1666 6 121, as com-
pared to 1034 6 95 in 2 to 3 week-old BDNF 2/2 mice,
a 1.6-fold decrease that was significantly different (p ,
0.02). Moreover, CST axon size was decreased from
.93 6 .01 mm2 to .70 6 mm2 in the absence of BDNF, a
result that was highly significant (p , 0.0001; n 5 3).
Thus, the lack of BDNF led to a decrease in bothsynaptic
innervation density and preganglionic axon number,
with the former being greater than the latter.
Discussion
Figure 5. Size Distribution of Unmyelinated and Myelinated Axons
in the CST of Adult Control Versus DBH:BDNF Transgenic Mice
Previous studies have led to the hypothesis that sympa-
(A–D) The size distribution of unmyelinated axons in cross-sections
thetic neurons produce growth factor(s) responsible forof the CST from lines D498 (A) and D481 (B) revealed a significant
shift to larger axons relative to controls. A similar shift to larger sizes
was observed for myelinated axons from these same two lines (C
(WT) animals revealed a shift of the entire curve to larger synapseand D). In this experiment, electron microscopic data similar to that
shown in Figure 4 was analyzed morphometrically. numbers in the DBH:BDNF mice. (F) Conversely, a histogram of the
synapse number per 41 mm2 grid in the SCG of 2- to 3-week-old(E and F) Distribution of synapse number in the SCG of adult control
versus DBH:BDNF transgenic mice and 2- to 3-week-old BDNF 1/1 BDNF 2/2 mice relative to their BDNF 1/1 littermates revealed a
shift of the entire curve to smaller synapse numbers in the absenceversus BDNF 2/2 mice. (E) A histogram of the synapse number per
41 mm2 grid in the SCG of adult line D498 (D498) versus control of BDNF.
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dynamically regulating the density of their preganglionic of preganglionic synapses per axon. Since the sympa-
thetic neuron number is not decreased in the BDNF 2/2innervation (Purves and Lichtman, 1980). In experiments
mice, this decreased innervation likely reflects a directpresented here, we demonstrate that sympathetic neu-
effect on preganglionic neurons. Such a deficit is remi-ron-derived BDNF is one growth factor that is likely to
niscent of the central nervous system of the NGF 2/2fulfill this role. In particular, our studies support this
mice, where the basal forebrain cholinergic neurons sur-conclusion with the following findings. First, they dem-
vive the loss of NGF, but the cholinergic innervationonstrate that both developing and mature sympathetic
density in the hippocampus is decreased. Together,neurons express BDNF protein, and that the pregangli-
these data indicate that one of the major functions ofonic neurons that innervate them express the full-length
neuron-derived neurotrophins may well be to dynami-TrkB/BDNF receptor. Second, they demonstrate that
cally regulate the level of synaptic innervation.when levels of sympathetic neuron-derived BDNF in-
Data presented here also provide support for the ideacrease, there is a coincident increase in the density of
that the levelof preganglionic innervation regulates sym-preganglionic synapses in the SCG, but no increase
pathetic neuron morphology. The somatic hypertrophyin the number of innervating axons and, presumably,
observed in the DBH:BDNF mice was not accompaniedneurons. Third, these studies demonstrate that when
by either increased numbers of sympathetic neuronsBDNF expression is lost in the BDNF 2/2 mice, there
and/or increased sympathetic target organ innervation.is a decrease in preganglionic axons innervating the
Moreover, removal of the preganglionic input to the SCGSCG, and an even larger decrease in the density
eliminated the size difference observed between controlof synaptic innervation per neuron. Together, these
and transgenic sympathetic neurons. On the basis ofstudies support the conclusion that sympathetic neu-
these observations, we propose that hyperinnervationron-derived BDNF selectively regulates the level of pre-
of sympathetic neurons leads to the observed increaseganglionic synaptic input.
in sympathetic soma size; such an increase may wellAlthough there is some precedent for these findings
be necessary to accommodate the increased numberwith regards to neuron–target organ interactions, there
of preganglionic synapses, and is likely accompanied byare also some major differences. The similarities are
increased dendritic complexity (Voyvodic, 1989). Whatlargely twofold. First, for neuron–target organ interac-
is the mechanism whereby the level of preganglionictions, the level of target innervation is modulated by
innervation could determine sympathetic neuron mor-
variations in target-derived growth factors; at the pre-
phology? Two likely possibilities involve an activity-
ganglionic–sympathetic synapse, variations in sympa-
dependent mechanism and/or a preganglionic antero-
thetic BDNF similarly modulated the level of pregangli-
grade trophic factor. Precedent for the latter derives
onic innervation. Second, increased terminally derived
from studies involving the neuromuscular junction,
NGF (Miller et al., 1994) or increased target territory
where evidence indicates that an anterograde myo-
(Voyvodic, 1989) retrogradely signal to mediate hyper- trophic factor, possibly a neuregulin (Florini et al., 1996;
trophy of peripheral neuron cell bodies; a similar retro- Falls et al., 1993), regulates muscle morphology and
grade preganglionic hypertrophy was observed here function. In fact, osteogenic protein-1 selectively causes
with increased sympathetic BDNF. However, there is sympathetic neuron dendritic growth and is a candidate
one major difference between the role of BDNF at this for such an anterograde factor (Lein et al., 1995); whether
neuronal synapse and NGF in the periphery. Competi- preganglionic neurons synthesize this growth factor has
tion for limiting amounts of NGF at the time of target not yet been determined.
innervation retrogradely determine the amount of sym- Together, these findings indicate that BDNF is a sym-
pathetic neuron cell death; increased exogenous NGF pathetic neuron-derived growth factor that dynamically
leads to the developmental rescue of these neurons regulates preganglionic innervation density. One predic-
and a corresponding increase in the number of neurons tion of this finding, based on earlier work at this synapse
innervating the same amount of target territory (re- (reviewed in Purves et al., 1988) is that variations in the
viewed in Levi-Montalcini, 1987). In contrast, even amount of peripheral NGF might regulate sympathetic
though the DBH promoter is induced at E10.5 (Kapur et neuron synthesis of BDNF, as has been shown for sen-
al., 1991), well before the postnatal period of axonal sory neurons (Apfel et al., 1996). If such an upregulation
pruning in the CST (Aguayo et al., 1973), there is no occurs in sympathetic neurons, then this would provide
increase in the number of axons in the CST of either the basis for a trophic factor cascade that could modify
line of transgenic mice. Instead, there is hypertrophy neuronal circuitry over more than one synapse (Purves
of preganglionic axons and a selective increase in the and Lichtman, 1980). For example, increases in sympa-
number of synapses per axon. Thus, sympathetic BDNF thetic target territory and NGF during normal growth
regulates the density of preganglionic innervation but would cause increased neuronal production of BDNF
not, apparently, the number of innervating neurons. and a consequent increase in preganglionic innervation.
This conclusion is supported by the data from the Moreover, this cascade would provide a mechanism for
BDNF 2/2 mice. Whereas the lack of target-derived dynamic alterations in preganglionic innervation as a
NGF leads to the loss of sympathetic and most sensory function of the amount of NGF available to any given
neurons in the NGF 2/2 mice (Crowley et al., 1994), neuron. In fact, dynamic remodelling of sympathetic
our CST axon counts indicate that many preganglionic neuron dendrites, and presumably synaptic input, has
neurons survive the loss of sympathetic-derived BDNF. been observed in adult animals (Purves et al., 1986).
Instead, there is a decrease in preganglionic innervation We propose that principles elucidated at this well
to the SCG, which is due to botha decrease in pregangli- characterized synapse generalize tomany neuronal syn-
apses in the CNS. It is now well documented that BDNFonic axon number and a decrease in the relative number
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sucrose solutions and sectioned on the cryostat prior to immunocy-can regulate both acute synaptic effects and neuronal
tochemical or morphometric analyses.morphology within the CNS (reviewed in Thoenen, 1995;
For resection experiments, animals were anaesthetized with so-Lo, 1995). Moreover, neuronal synthesis of BDNF is reg-
dium pentobarbital (35 mg/kg), and the cervical sympathetic trunk
ulated as a function of neural activity (Zafra et al., 1990; (CST), which carries the preganglionic axons to the SCG, was unilat-
Patterson et al., 1992; Nawa et al., 1995). We propose, erally transected approximately 1–2 mm from the base of the SCG.
To prevent regeneration, a piece of the nerve was removed. Foron the basis of data presented here, that activity-depen-
electron microscopy (EM), animals were anaesthetized as describeddent variations in neuronal BDNF synthesis could lead
above. The SCG were removed with approximately 3 mm of theto long-term alterations in synaptic input. Such a model
CST attached, immersion-fixed in 1.6% glutaraldehyde in 0.1M PBwould provide a mechanism whereby levels and pat-
(pH 7.3), and processed for EM as described below.
terns of neuronal activity sufficient to increase neuronal
BDNF synthesis, such as LTP (Patterson et al., 1992), RNA Isolation and Analysis
could lead to permanent alterations in synaptic input Total and poly A1 RNA were isolated from cultured L cells and
sympathetic ganglia, and 32P-labeled BDNF antisense RNA probesdensity on a per-neuron level. Moreover, a trophic factor
were used to probe Northern blots as previously described (Achesoncascade such as that observed for the target organ–
et al., 1991). RNase-protection assays were performed using thesympathetic neuron–preganglionic neuron circuit could
same BDNF riboprobe as previously described (Chibbar et al., 1993).
well serve to propagate such changes over several cen-
tral synapses. Western Blot Analysis
Ganglia, brains, and spinal cord tissue were lysed in Tris-buffered
saline (TBS) lysis buffer containing 137 mM NaCl, 20 mM Tris (pHExperimental Procedures
8.0), 1% (v/v) NP-40, 10% v/v glycerol, 1 mM phenylmethylsulfonyl-
fluoride (PMSF), 10 mg/ml aprotinin, 0.2 mg/ml leupeptin, and 0.1%Construction of the DBH:BDNF Transgenic Mice
SDS. Samples were rocked for 20 min at 48C and centrifuged forThe 1.6 kb DBH promoter (Hoyle et al., 1994) was isolated by digest-
15 min at 15,000 rpm. The supernatant was normalized for proteining a 9.0 kb Eco RI fragment of the human DBH gene (Mercer et
concentration using a BSA protein assay reagent (Pierce, Rockford,al., 1991; gift of E. Mercer and R. Palmiter) with Sph I and Sty I.
IL). Supernatants were boiled in sample buffer (2% SDS, 100 mMThe 1.6 kb DBH fragment was subsequently isolated, purified, and
dithiothreitol, 10% glycerol, 0.05% bromophenol blue) for 5 min,subcloned into the Hinc II and Sph I sites in pGEM4Z (Promega).
followed by SDS-PAGE. For analysis of blood samples, 1 ml of bloodThe BDNF open reading frame (Leibrock et al., 1989) was isolated
was added to the same protease inhibitors plus heparin, centrifugedby RT-PCR from rat brain mRNA, sequenced, and cloned into the
for 5 min, and the serum removed. 0.5% trifluoroacetic acid (TFA)Bam HI and Hind III sites of pBluescript (Stratagene). A 1.0 kb Bam
in H2O was added to 0.5 ml of serum, and, after centrifugation, 0.5HI fragment that contained an SV40 intron and polyadenylation sig-
ml of the supernatant was purified by Sep-Pak C18, concentratednal was subcloned into the Bam HI site downstream of the BDNF
by speed vacuum, and analyzed by SDS-PAGE. As a control for theopen reading frame. The 1.6 kb DBH promoter was then isolated
specificity of the BDNF antibody, recombinant BDNF and/or lysatesfrom pGEM4Z (Promega) by Hpa II digestion and subcloned into
from PC12 cells infected with a vaccinia virus expressing the humanthe Cla I site upstream of the BDNF open reading frame. The resul-
BDNF open reading frame were used (the latter the kind gift of Drs.tant 3.4 kb minigene was sequenced and isolated free of vector
Sangeeta Pareek and Richard Murphy, MNI). After electrophoresis,sequences by digestion of the plasmid with BssHII. Transgenic mice
proteins were transferred to 0.2 mm nitrocellulose for 1 hr at 0.5were generated from the DBH:BDNF transgene by the Canadian
Amps. Membranes were washed 3 3 10 min in dH2O followed byNeuroSciences Network transgenic core facility (McGill University).
2 3 10 min in PBS. Following the washes, membranes were blocked
in 5% nonfat dry milk in PBST (PBS 1 0.1% Tween) for 2 hr at room
Genotyping of Transgenic Animals temperature, then incubated with an antibody directed against a
DBH:BDNF mice were genotyped using Southern blot analysis and/ peptide specific to BDNF (Santa Cruz; 1:5000) overnight at 48C. For
or PCR on tail DNA extracts. For Southern blot analysis, genomic preabsorption studies, 5 mg of the BDNF peptide immunogen (Santa
DNA was digested with Sal I, separated on 1% agarose gels, trans- Cruz) was added to 0.2 mg BDNF antibody and incubated at 48C
ferred to nitrocellulose, and probed with a 32P-labeled riboprobe overnight. Membranes were subsequently washed 3 3 10 min in
directed against sequences in the 1.6 kb human DBH promoter, PBST, incubated with a goat anti-rabbit horseradish peroxidase–
using standard techniques. Mice heterozygous for a targeted muta- conjugated secondary antibody (1:10,000; Boehringer Mannheim)
tion in the BDNF gene (Ernfors et al., 1994) were obtained from for 1 hr at room temperature, then washed 3 3 10 min in PBST.
Jackson Labs (Bar Harbor). Progeny from BDNF heterozygote Following manufacturer’s protocols, proteins were detected using
crosses were screened for the mutant allele(s) using PCR. enhanced chemiluminescence (Amersham) and XAR film (Kodak).
Blots were quantitated using NIH Image Software.
Animals and Surgical Procedures
For biochemical analysis, animals were sacrificed with sodium pen- Immunocytochemistry
The following primary antibodies were used for immunocytochemis-tobarbital, and tissues were immediately removed and processed
for Northern blots, RNase-protection assays, and Western blots. try: anti-peptide antibodies specific to sequences in BDNF (Pat-
terson et al., 1996) and the full-length form of TrkB (TrkBin; Allen-For immunocytochemical and morphometric analyses,animals were
anaesthesized with sodium pentobarbital (35 mg/kg) for 30 min. For doerfer et al., 1994) (both the kind gift of Dr. David Kaplan), synapsin
(kind gift of Dr. Paul Greengard), and commercially available anti-immunocytochemistry, the SCG were removed, and immersion fixed
in 4% paraformaldehyde/15% picric acid in phosphate buffer (PB, bodies against ChAT (Chemicon) and tyrosine hydroxylase (Pel-
freeze). For all antibodies, following cryoprotection, tissue was fro-pH 7.4) for 30 min at 48C, and subsequently cleared of picric acid
with phosphate-buffered saline (PBS, pH 7.4). For morphometric zen, and 10–16-mm-thick sections were cut on a cryostat and
mounted on chrom-alum–subbed slides. For the BDNF, TrkBin, andanalysis, the SCG were removed and immersion-fixed in 4% parfor-
maldehyde in PB for 1 hr to overnight at 48C. For immunocytochemi- synapsin antibodies, sections were postfixed with 4% paraformal-
dehyde in PB for 2 min at room temperature and washed 2 3 15cal analysis of the spinal cord, animals were transcardially perfused
with 4% paraformaldehyde in PB. Subsequent to transcardial perfu- min in 1M HEPES-buffered saline (HBS, pH 7.4) 1 0.2%Triton X-100.
Following nonspecific blocking with 10% serum for 45 min at roomsion, the spinal cord from thoracic levels 1–4 was removed and
postfixed in 4% paraformaldehyde in PB for 30 min. For immunocy- temperature, sections were incubated with the primary antibodies
in HBS 1 0.2% Triton X-100 1 10% serum overnight at 48C attochemical analysis, the pineal gland was carefully removed and
immersion-fixed in 4% paraformaldehyde in phosphate buffer at 48C dilutions of 1:200 for anti-BDNF and TrkBin, and 1:500 for synapsin.
Slides were then washed 3 3 15 min in HBS 1 0.2% Triton X-100.overnight. All tissues were subsequently cryoprotected in graded
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Binding of primary antibodies was visualized with a rhodamine- density. In all cases, statistical results were expressed as mean
values 6 the standard error of the mean and were tested for signifi-conjugated secondary antibody (donkey anti-rabbit IgG at a 1:200
dilution; Jackson). Slides were then washed, mounted with a 10% cance by the Student’s t-test for paired differences.
glycerol–90% PBS solution, and coverslipped. For ChAT immunocy-
tochemistry, the primary antibody was utilized as above (1:1800 Acknowledgments
dilution), but was then visualized using a biotin-conjugated second-
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Samples of SCG with 3 mm of attached CST were immersion-fixed
Received August 27, 1996; revised January 14, 1997.in 1.6% glutaraldehyde in 0.1M PB (pH 7.3). Samples were postfixed
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